Swisstom AG
Experience the future of bedside imaging with real-time, non-radiating lung monitoring for life-saving care in intensive settings.
Experience the future of bedside imaging with real-time, non-radiating lung monitoring for life-saving care in intensive settings.
Swisstom AG is a Swiss-based startup that specializes in the development and production of groundbreaking medical devices. The company's latest lung function monitor provides crucial treatments for patients in intensive care and under general anesthesia. Unlike conventional tomography, Swisstom's bedside imaging utilizes non-radiating principles through Electrical Impedance Tomography (EIT). The company gained its most recent Series C investment from Zühlke Ventures AG on 17 July 2014. This investment showcases the confidence Zühlke Ventures AG has in Swisstom AG's potential to revolutionize the field of medical technology. Swisstom's advantage lies in its dedicated leadership in non-invasive tomography, aiming to enhance individual lives and medical therapies. With a focus on biotechnology, health care, and manufacturing, Swisstom AG is poised to make a significant impact in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | Unknown | 1 |
|
17 Jul 2014 |
| Series B | Unknown | 1 |
|
10 Jan 2013 |
| Series A | Unknown | - | 30 Sep 2012 | |
| Grant | Unknown | - | 24 Aug 2011 |
No recent news or press coverage available for Swisstom AG.
We care about your data, and we'd love to use cookies make your experience better.
